161 related articles for article (PubMed ID: 30177680)
1. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication.
Shirasaki T; Honda M; Yamashita T; Nio K; Shimakami T; Shimizu R; Nakasyo S; Murai K; Shirasaki N; Okada H; Sakai Y; Sato T; Suzuki T; Yoshioka K; Kaneko S
Sci Rep; 2018 Sep; 8(1):13143. PubMed ID: 30177680
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma.
Gao X; Sheng Y; Yang J; Wang C; Zhang R; Zhu Y; Zhang Z; Zhang K; Yan S; Sun H; Wei J; Wang X; Yu X; Zhang Y; Luo Q; Zheng Y; Qiao P; Zhao Y; Dong Q; Qin L
J Exp Clin Cancer Res; 2018 Jul; 37(1):179. PubMed ID: 30064482
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis.
Nallasamy P; Nimmakayala RK; Karmakar S; Leon F; Seshacharyulu P; Lakshmanan I; Rachagani S; Mallya K; Zhang C; Ly QP; Myers MS; Josh L; Grabow CE; Gautam SK; Kumar S; Lele SM; Jain M; Batra SK; Ponnusamy MP
Gastroenterology; 2021 Dec; 161(6):1998-2013.e7. PubMed ID: 34418441
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of osteopontin and CD44 correlates with infertility status in PCOS patients.
Paravati R; De Mello N; Onyido EK; Francis LW; Brüsehafer K; Younas K; Spencer-Harty S; Conlan RS; Gonzalez D; Margarit L
J Mol Med (Berl); 2020 Dec; 98(12):1713-1725. PubMed ID: 33047155
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
Desai B; Rogers MJ; Chellaiah MA
Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
[TBL] [Abstract][Full Text] [Related]
6. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
Liu F; Wu X; Jiang X; Qian Y; Gao J
J Exp Clin Cancer Res; 2018 Jun; 37(1):122. PubMed ID: 29940988
[TBL] [Abstract][Full Text] [Related]
7. Beta-Hydroxyisovaleryl-Shikonin Eradicates Epithelial Cell Adhesion Molecule-Positive Liver Cancer Stem Cells by Suppressing dUTP Pyrophosphatase Expression.
Asahina Y; Takatori H; Nio K; Okada H; Hayashi T; Hayashi T; Hashiba T; Suda T; Nishitani M; Sugimoto S; Honda M; Kaneko S; Yamashita T
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003473
[TBL] [Abstract][Full Text] [Related]
8. Cellular and Molecular Biology of Cancer Stem Cells of Hepatocellular Carcinoma.
Jeng KS; Chang CF; Sheen IS; Jeng CJ; Wang CH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674932
[TBL] [Abstract][Full Text] [Related]
9. Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer.
Gao Y; Li Y; Zhu Y; Luo Q; Lu Y; Wen K; Du B; Xi X; Li G
Curr Cancer Drug Targets; 2024; 24(5):510-518. PubMed ID: 38099524
[TBL] [Abstract][Full Text] [Related]
10. c-Met activation through a novel pathway involving osteopontin mediates oncogenesis by the transcription factor LSF.
Yoo BK; Gredler R; Chen D; Santhekadur PK; Fisher PB; Sarkar D
J Hepatol; 2011 Dec; 55(6):1317-24. PubMed ID: 21703197
[TBL] [Abstract][Full Text] [Related]
11. Interferon alpha regulates MAPK and STAT1 pathways in human hepatoma cells.
Zhao LJ; Hua X; He SF; Ren H; Qi ZT
Virol J; 2011 Apr; 8():157. PubMed ID: 21466707
[TBL] [Abstract][Full Text] [Related]
12. EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes.
Mani SK; Zhang H; Diab A; Pascuzzi PE; Lefrançois L; Fares N; Bancel B; Merle P; Andrisani O
J Hepatol; 2016 Nov; 65(5):888-898. PubMed ID: 27238755
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype.
Krause J; von Felden J; Casar C; Fründt TW; Galaski J; Schmidt C; Jung C; Ittrich H; Weidemann SA; Krech T; Heumann A; Li J; Fischer L; Sauter G; Lohse AW; Wege H; Schulze K
BMC Cancer; 2020 Nov; 20(1):1130. PubMed ID: 33225916
[TBL] [Abstract][Full Text] [Related]
14. The CD44std and CD44v9 subpopulations in non-tumorigenic invasive SNU-423 cells present different features of cancer stem cells.
Aguilar-Chaparro MA; Rivera-Pineda SA; Hernández-Galdámez HV; Piña-Vázquez C; Villa-Treviño S
Stem Cell Res; 2023 Oct; 72():103222. PubMed ID: 37844417
[TBL] [Abstract][Full Text] [Related]
15. NDRG1 facilitates self-renewal of liver cancer stem cells by preventing EpCAM ubiquitination.
Cheng Q; Ning S; Zhu L; Zhang C; Jiang S; Hao Y; Zhu J
Br J Cancer; 2023 Aug; 129(2):237-248. PubMed ID: 37165202
[TBL] [Abstract][Full Text] [Related]
16. Chaperone-Mediated Autophagy in the Liver: Good or Bad?
Dash S; Aydin Y; Moroz K
Cells; 2019 Oct; 8(11):. PubMed ID: 31652893
[TBL] [Abstract][Full Text] [Related]
17. CD44: A Multifunctional Mediator of Cancer Progression.
Hassn Mesrati M; Syafruddin SE; Mohtar MA; Syahir A
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944493
[TBL] [Abstract][Full Text] [Related]
18. Common Variants in Osteopontin and
Gałecki S; Gdowicz-Kłosok A; Deja R; Masłyk B; Giglok M; Suwiński R; Butkiewicz D
Cells; 2023 Nov; 12(23):. PubMed ID: 38067149
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of osteopontin isoforms in malignant melanoma cell lines.
Koroknai V; Szász I; Jámbor K; Balázs M
Clin Transl Sci; 2024 Jan; 17(1):e13694. PubMed ID: 38058256
[TBL] [Abstract][Full Text] [Related]
20. CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.
Williams K; Motiani K; Giridhar PV; Kasper S
Exp Biol Med (Maywood); 2013 Mar; 238(3):324-38. PubMed ID: 23598979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]